Trials / Completed
CompletedNCT02541214
Evaluation of a Nasal Mask for the Treatment of Obstructive Sleep Apnea in New Zealand
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Fisher and Paykel Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Currently, Fisher and Paykel Healthcare (FPH) is developing a new nasal mask. This investigation is designed to evaluate the performance of the trial nasal mask, focused specifically on how the different seal sizes will perform on Obstructive Sleep Apnea participants who are currently on Positive Airway Pressure therapy. Participant's prescribed treatment pressure with their usual mask will be collected for 7 days ± 3 days prior to mask fitting with the trial nasal mask. They will then be issued with the trial nasal mask to use in-home for 14 days ± 4 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Trial Nasal Mask |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-10-01
- Completion
- 2015-11-01
- First posted
- 2015-09-04
- Last updated
- 2019-08-02
Locations
2 sites across 1 country: New Zealand
Source: ClinicalTrials.gov record NCT02541214. Inclusion in this directory is not an endorsement.